Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,337 public trials 2,831 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

NCT07154823

Conditions
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL), Hematologic Diseases, +15 more
Locations
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Cancer Care Specialists of Reno Reno, Nevada, United States
View Trial Details
Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

NCT06714591

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Ronald Reagan Medical Center Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

NCT06892522

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center /ID# 273132 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911 Irvine, California, United States
  • Colorado Blood Cancer Institute /ID# 273129 Denver, Colorado, United States
  • Moffitt Cancer Center /ID# 272628 Tampa, Florida, United States
View all 34 locations
View Trial Details
Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

NCT07091019

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Stockton Hematology Oncology Medical Group Inc Stockton, California, United States
  • Lundquist Inst BioMed at Harbor Torrance, California, United States
  • Stamford Hospital Stamford, Connecticut, United States
View all 17 locations
View Trial Details

Related conditions